Patents by Inventor Robert A. RUBIN

Robert A. RUBIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10725039
    Abstract: The present invention relates to methods for the diagnosing, prognosing, monitoring, differentiating, treating, and managing of Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature comprised of a combination of two or more analytes indicative of disease.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: July 28, 2020
    Assignee: VERAMARX, INC.
    Inventors: Whitney Richards, Floyd E. Taub, Robert A. Rubin
  • Patent number: 10725038
    Abstract: The present invention relates to methods for the differentiating, diagnosing, and treating Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature capable of differentiating Lyme disease from like-symptom diseases, the biomarker signature being comprised of a combination of two or more analytes.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: July 28, 2020
    Assignee: VERAMARX, INC.
    Inventors: Whitney Richards, Floyd E. Taub, Robert A. Rubin
  • Publication number: 20190204316
    Abstract: The present invention relates to methods for the diagnosing, prognosing, monitoring, differentiating, treating, and managing of Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature comprised of a combination of two or more analytes indicative of disease.
    Type: Application
    Filed: March 11, 2019
    Publication date: July 4, 2019
    Inventors: Whitney RICHARDS, Floyd E. TAUB, Robert A. RUBIN
  • Patent number: 10274491
    Abstract: The present invention relates to methods for the diagnosing, prognosing, monitoring, differentiating, treating, and managing of Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature comprised of a combination of two or more analytes indicative of disease.
    Type: Grant
    Filed: July 7, 2015
    Date of Patent: April 30, 2019
    Assignee: VERAMARX, INC.
    Inventors: Whitney Richards, Floyd E. Taub, Robert A. Rubin
  • Publication number: 20190033310
    Abstract: The present invention relates to methods for the differentiating, diagnosing, and treating Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature capable of differentiating Lyme disease from like-symptom diseases, the biomarker signature being comprised of a combination of two or more analytes.
    Type: Application
    Filed: January 6, 2016
    Publication date: January 31, 2019
    Inventors: Whitney Richards, Floyd E. Taub, Robert A. Rubin
  • Publication number: 20170336409
    Abstract: The present invention relates to methods for the diagnosing, prognosing, monitoring, differentiating, treating, and managing of Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature comprised of a combination of two or more analytes indicative of disease.
    Type: Application
    Filed: July 7, 2015
    Publication date: November 23, 2017
    Applicant: VERAMARX, INC.
    Inventors: Whitney RICHARDS, Floyd E. TAUB, Robert A. RUBIN